Shares of BioSyent Inc. (CVE:RX – Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$11.05 and traded as high as C$11.30. BioSyent shares last traded at C$11.30, with a volume of 1,158 shares traded.
BioSyent Stock Up 1.3 %
The stock’s 50-day moving average price is C$11.05 and its two-hundred day moving average price is C$11.13. The company has a current ratio of 3.92, a quick ratio of 6.91 and a debt-to-equity ratio of 2.90. The stock has a market capitalization of C$129.24 million, a P/E ratio of 18.34 and a beta of 0.93.
BioSyent Company Profile
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Featured Articles
- Five stocks we like better than BioSyent
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Energy Transfer: Powering Data With Dividends and Diversification
- What does consumer price index measure?
- Qualcomm Stock Is Coiling for a Breakout
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
